CenterPoint Energy plans $250 million stock sale
HOUSTON – CenterPoint Energy, Inc. (NYSE: NYSE:) has announced its intention to launch an underwritten...
Business
Tim Walz and JD Vance agree on something: Diet Mountain Dew. But is the nonpartisan pop healthy?
The chartreuse soda contains three artificial sweeteners and various additives. How safe are they?
Memecoins are the hottest sector in crypto—but 97% of them are already dead
A new report offers a sobering reminder of the perils of investing and trading in the currency of internet humor.
Intel, now struggling against AI competitors, turned down an opportunity to own 15% of OpenAI
OpenAI is now worth about the same as the semiconductor company.
JPMorgan’s Jamie Dimon confirms his hit-by-a-bus CEO pick for the bank
“Eventually, I have to leave—I know that,” said Dimon.
A guide to a nurse’s salary: Broken down by all 50 states and industry type
Nurses in California make over double those working in Alabama.
French explorer’s family sues for $50 million over implosion death
“Common sense dictates that the crew were well aware they were going to die, before dying," the lawsuit alleges.
YCBD stock touches 52-week low at $0.53 amid market challenges
In a challenging market environment, shares of cbdMD, Inc. (NYSE:) have reached a 52-week low,...
Invenra Highlights Exelixis’ Announcement: Initiation of Phase 1 Clinical Trial Evaluating XB010 in Patients with Advanced Solid Tumors
MADISON, Wisc.–(BUSINESS WIRE)–Invenra’s collaboration partner, Exelixis, Inc. (NASDAQ: NASDAQ:) has announced the initiation of the...
